Learn About Sex-Related Health Issues. Get the facts on sexually transmitted diseases, prostate issues, pregnancy, impotence, menopause, birth control and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Testicular Cancer Survivors May Have Hormone Deficiency

Too little testosterone can affect quality of life, researchers say

MONDAY, Feb. 22 (HealthDay News) -- Testosterone deficiency in young male cancer survivors often causes low energy levels and reduced quality of life, and these patients may benefit from testosterone replacement therapy, a new study suggests.

About 15 percent of male cancer survivors experience testosterone deficiency, which is a late side effect of chemotherapy or radiation therapy.

Advertisement
Related Stories
 border=
Smoking Could Harm Sperm, Study Finds
New Tool Aims to Predict Problems in Preemies
Kids on HIV Drug Cocktail May Need Revaccination
Related Videos
 border=
How Do I Adhere to My HIV Medications?
How Do I Use a Male and Female Condom?
How Do I Get an HIV Test?
Related Slides
 border=
Penile Implants
Placenta Abruptio
PMS
Related Encyclopedia
 border=
AIDS and HIV Infection
Bashful Bladder Syndrome
Birth Control


In this study of 176 young male cancer survivors and 213 young men without cancer, English researchers looked at the association between testosterone levels, quality of life, self-esteem, fatigue and sexual function.

The young male cancer survivors reported reduced energy levels, impaired sexual function and a markedly reduced quality of life. These problems were most severe in those with testosterone deficiency.

However, the cancer survivors had no problems with self-esteem, sexual relationships or mental health.

"This is an important study demonstrating that low testosterone levels are common in male cancer survivors and associated with an impaired quality of life," said lead investigator Dr. Richard Ross, of the University of Sheffield. "However, the relationship between testosterone levels and quality of life is complex and appears to depend on a threshold level rather than on a direct correlation. We now need interventional trials with testosterone to determine which young male cancer survivors will benefit from replacement therapy."

The study was published online Feb. 22 in the journal Cancer.

More information

The U.S. Centers for Disease Control and Prevention has more about cancer and men.

-- Robert Preidt

SOURCE: Cancer, news release, Feb. 22, 2010

Copyright © 2010 HealthDay. All rights reserved.
Last updated 2/22/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Sep 9, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Erectile Facts
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: